Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: Implications in the treatment of restenosis after angioplasty

This publication has 20 references indexed in Scilit:

• Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients
  Journal of the American College of Cardiology, 1991
• Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty.
  Circulation Research, 1990
• Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
  Journal of the American College of Cardiology, 1990
• The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty
  American Heart Journal, 1990
• Platelet inhibitor agents in cardiovascular disease: An update
  Journal of the American College of Cardiology, 1989
• Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
  New England Journal of Medicine, 1988
• Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty
  Journal of the American College of Cardiology, 1985
• Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.
  Circulation Research, 1985
• Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations
  New England Journal of Medicine, 1984
• Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.
  Heart, 1983